GlassScriptPhysician profile
Hayden Kassels
NPI 1487281598
$2,623.70
in general payments reported to CMS, 2019-2025
13 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.43 · 2023: $86.25 · 2024: $38.93 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $641 · Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $641.45 |
| Food and Beverage | $460.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,247.48 | 2025 | |
| Sage Therapeutics, LLC | $86.83 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $50.53 | 2023-2025 | Veozah |
| Supernus Pharmaceuticals, INC. | $45.40 | 2025 | Qelbree |
| Boston Scientific Corporation | $32.38 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Sumitomo Pharma America, INC. | $25.27 | 2024 | Myfembree |
| Mayne Pharma Commercial LLC | $24.54 | 2025 | |
| Kci USA, INC. | $21.43 | 2022 | |
| Medicem INC. | $21.29 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.81 | 2025 | |
| Davol INC. | $18.79 | 2023 | Arista Ah Flexitip |
| Dexcom, INC. | $16.29 | 2023 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $13.66 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayden Kassels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.